1 Subjects: “...Disease Progression...”

2 Subjects: “...Disease Progression...”

3 “...PURPOSE: We compared the effectiveness and harms of fingolimod (Gilenya) to other disease-modifying...”

4 “...There was no difference in relapse or disease progression between glatiramer and interferon beta-1a...”

5 Subjects: “...Chronic Disease / drug therapy...”

6 Subjects: “...Vascular Diseases / drug therapy...”

7 Subjects: “...Musculoskeletal Diseases / drug therapy...”

8 Subjects: “...Coronary Disease / prevention & control...”

9 Subjects: “...Cardiovascular Diseases / drug therapy...”

10 Subjects: “...Inflammatory Bowel Diseases / drug therapy...”

11 Subjects: “...Cardiovascular Diseases / drug therapy...”

12 Subjects: “...Cardiovascular Diseases / drug therapy...”

13 “...In the United States, coronary heart disease and cardiovascular disease account for nearly 40...”

14 “...'s disease, ulcerative colitis, and plaque psoriasis that substantially improve the burden of disease...”

15 “...'s disease, ulcerative colitis, and plaque psoriasis that substantially improve the burden of disease...”

16 “... and placebo and between AIIRAs and ACEIs in the treatment of diagnosed coronary heart disease, hypertension...”

17 “... and placebo and between AIIRAs and ACEIs in the treatment of diagnosed coronary heart disease, hypertension...”

18 “... and inflammatory diseases, including rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis...”

19 “..., bleeding esophageal varices, coronary artery disease, asymptomatic and symptomatic heart failure, migraine...”

20 “... besides symptom management (osteoporosis) as well as potential harms (cardiovascular disease, breast...”